**🚨 NEW RESEARCH IN AFRICA SHATTERS ALZHEIMER’S MYTH — AND IT CHANGES EVERYTHING 🚨**
**By BWS | The Realist. The Rebel. The Researcher.**
—
LADIES AND GENTLEMEN
If you’ve been sleeping on the real science behind Alzheimer’s disease and what it means for Black people globally, today is the day you wake up. Because I just read a study that *explodes* the entire mainstream narrative about Alzheimer’s risk — and it all comes from Nigeria.
That’s right. **Africa. Nigeria. Yoruba people.** And this research? It’s not just groundbreaking. It’s **revolutionary**.
Let me break this down like I’m breaking glass with a sledgehammer:
The so-called “gold standard” of Alzheimer’s risk — the APOE ε4 allele — does **NOT** have the same effect in Nigerian populations as it does in European or even African American populations.
Say that again?
**APOE ε4 — the supposed “Alzheimer’s gene” — doesn’t predict Alzheimer’s in Nigerians. Not consistently. Not reliably. Not even close.**
And that changes *everything.*
—
### 🔬 WHAT IS APOE ε4 ANYWAY?
For those who don’t speak genetics fluently:
– **APOE ε4** is one of three major alleles of the apolipoprotein E (APOE) gene.
– In European populations, having one copy increases your risk of Alzheimer’s. Two copies? Even worse.
– For years, this has been used as a kind of genetic crystal ball to estimate dementia risk.
But here’s the crux:
**In the Yoruba population in Nigeria? No link. Zero. Zilch. Nada.**
This isn’t just some obscure finding buried in a dusty academic journal. This is coming out of the **Indianapolis-Ibadan Dementia Project**, one of the most long-standing cross-cultural studies on aging and dementia.
So we’re talking *real science*, done *right*, over *decades*. Not woke clickbait. Not pseudoscience. Legit data.
—
### 🧠 BUT IF APOE ε4 DOESN’T CAUSE ALZHEIMER’S IN NIGERIANS… WHAT DOES?
Great question. And guess what? Scientists are finally asking it too.
New research shows that other genes — **ABCA7**, **CLU**, and **SLC24A4** — might be the real culprits when it comes to Alzheimer’s risk in Nigerian populations.
These genes are involved in:
– Cholesterol transport (ABCA7),
– Protein clustering in the brain (CLU),
– Calcium signaling and ion exchange (SLC24A4).
And none of them get nearly as much attention as APOE ε4 — especially when it comes to studying African populations.
Why?
Because Big Pharma, Big Science, and Big Academia have spent decades assuming that biology works the same way across all races and ethnicities.
Spoiler: **It doesn’t.**
—
### 💥 THIS SHATTERS THE WHOLE WESTERN BIASED MODEL OF DISEASE
We’ve been treating Alzheimer’s like it’s one-size-fits-all.
It’s not.
And if you think this only matters for Nigerians, you’re missing the point.
This discovery is a **slap in the face** to the entire Western medical establishment that continues to ignore genetic diversity in medicine.
You want personalized medicine?
Then stop pretending that a genetic marker found in Europeans tells us anything useful about the health of Africans, Asians, or Indigenous peoples.
We are NOT the same.
And we need research that reflects that.
—
### 🌍 WHY THIS MATTERS GLOBALLY
Here’s why this matters to YOU — wherever you are:
1. **More accurate diagnosis:** If we keep using APOE ε4 as the main indicator for Alzheimer’s risk, we’re going to misdiagnose millions of people of African descent. That’s not just bad science — it’s dangerous.
2. **Better treatments:** Once we understand which genes actually matter in different populations, we can develop better drugs and therapies. Ones that work. Not ones that just work for white people.
3. **Empowerment through knowledge:** This research gives us power. It gives us agency. It gives us the truth. And truth is the ultimate weapon against misinformation and systemic bias.
—
### 🧬 WE NEED TO FUND AFRICAN GENOMICS — NOW
Africa has the most genetic diversity of any continent on Earth.
Yet less than 2% of all genome-wide association studies include African populations.
Let that sink in.
We are the origin of humanity — and yet we’re treated like an afterthought in modern genetics.
Well, no more.
This research proves that **if you don’t study African genomes, you’re flying blind.**
And flying blind in medicine?
That’s called malpractice.
—
### 🔥 FINAL THOUGHTS FROM THE TOP GEAR
Listen up.
Science should never be afraid of truth.
And truth is, the old model is broken.
We can’t keep using European-centric data to make life-or-death decisions for people all over the world.
This new research from Nigeria isn’t just important.
It’s **revolutionary.**
It changes how we think about Alzheimer’s.
It changes how we think about race and medicine.
And it changes how we think about the future of healthcare.
So if you care about real science, real data, and real solutions — share this post.
Tag your doctor.
Tag your professor.
Tag your senator.
Because this isn’t just a Nigerian story.
This is a **global wake-up call.**
—
**🔥 Stay sharp. Stay informed. Stay unapologetically curious.**
—BWS CONCIERGE
P.S. If you found this article useful, hit that share button like you’re hitting a Tesla window with a hammer. Knowledge is power — and this is the kind of power that breaks myths wide open.
HOW TO CONSULT WITH BWS?
Rates: $100 | 30 minute
Contact: TO PARTNER OR FOR CONSULTATION
Emeritus Prof Ifeoma Okoye
Email: sales@slaynetwork.co.uk
Website: https://slaylebrity.com/users/pinkyprof/
Instagram: @pinkyprof_wellness
PS: If you will like to join Slaylebrity VIP social network pls contact sales@slaynetwork.co.uk and include referred by BWS in your subject cheers!
NEW RESEARCH IN AFRICA SHATTERS ALZHEIMER’S MYTH — AND IT CHANGES EVERYTHING The so-called gold standard of Alzheimer’s risk — the APOE ε4 allele — does **NOT** have the same effect in Nigerian populations as it does in European or even African American populations. Say that again?
APOE ε4 — the supposed Alzheimer’s gene — doesn’t predict Alzheimer’s in Nigerians. Not consistently. Not reliably. Not even close.** And that changes *everything.*
APOE ε4** is one of three major alleles of the apolipoprotein E (APOE) gene. - In European populations, having one copy increases your risk of Alzheimer’s. Two copies? Even worse. - For years, this has been used as a kind of genetic crystal ball to estimate dementia risk.
